Literature DB >> 24615470

PET imaging of garbage protein in Alzheimer's disease: does it require reappraisal of brain PET analysis?

Serge Goldman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24615470     DOI： 10.1007/s00259-014-2740-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  14 in total

1.  Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction.

Authors:  Mario Quarantelli; Karim Berkouk; Anna Prinster; Brigitte Landeau; Claus Svarer; Laszlo Balkay; Bruno Alfano; Arturo Brunetti; Jean-Claude Baron; Marco Salvatore
Journal:  J Nucl Med       Date:  2004-02       Impact factor: 10.057

2.  Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls.

Authors:  Masahiro Maruyama; Hitoshi Shimada; Tetsuya Suhara; Hitoshi Shinotoh; Bin Ji; Jun Maeda; Ming-Rong Zhang; John Q Trojanowski; Virginia M-Y Lee; Maiko Ono; Kazuto Masamoto; Harumasa Takano; Naruhiko Sahara; Nobuhisa Iwata; Nobuyuki Okamura; Shozo Furumoto; Yukitsuka Kudo; Qing Chang; Takaomi C Saido; Akihiko Takashima; Jada Lewis; Ming-Kuei Jang; Ichio Aoki; Hiroshi Ito; Makoto Higuchi
Journal:  Neuron       Date:  2013-09-18       Impact factor: 17.173

3.  A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography.

Authors:  M A Mintun; M E Raichle; M R Kilbourn; G F Wooten; M J Welch
Journal:  Ann Neurol       Date:  1984-03       Impact factor: 10.422

4.  In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET.

Authors:  Gunnar Antoni; Mark Lubberink; Sergio Estrada; Jan Axelsson; Kristina Carlson; Lars Lindsjö; Tanja Kero; Bengt Långström; Sven-Olof Granstam; Sara Rosengren; Ola Vedin; Cecilia Wassberg; Gerhard Wikström; Per Westermark; Jens Sörensen
Journal:  J Nucl Med       Date:  2012-12-13       Impact factor: 10.057

5.  Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo.

Authors:  Marc I Diamond; David M Holtzman; Kiran Yanamandra; Najla Kfoury; Hong Jiang; Thomas E Mahan; Shengmei Ma; Susan E Maloney; David F Wozniak
Journal:  Neuron       Date:  2013-09-26       Impact factor: 17.173

6.  Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease.

Authors:  Nobuyuki Okamura; Shozo Furumoto; Ryuichi Harada; Tetsuro Tago; Takeo Yoshikawa; Michelle Fodero-Tavoletti; Rachel S Mulligan; Victor L Villemagne; Hiroyasu Akatsu; Takayuki Yamamoto; Hiroyuki Arai; Ren Iwata; Kazuhiko Yanai; Yukitsuka Kudo
Journal:  J Nucl Med       Date:  2013-07-15       Impact factor: 10.057

7.  Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.

Authors:  Julie C Price; William E Klunk; Brian J Lopresti; Xueling Lu; Jessica A Hoge; Scott K Ziolko; Daniel P Holt; Carolyn C Meltzer; Steven T DeKosky; Chester A Mathis
Journal:  J Cereb Blood Flow Metab       Date:  2005-11       Impact factor: 6.200

8.  A new roadmap for drug development for Alzheimer's disease.

Authors:  Robert E Becker; Nigel H Greig; Ezio Giacobini; Lon S Schneider; Luigi Ferrucci
Journal:  Nat Rev Drug Discov       Date:  2013-12-20       Impact factor: 84.694

9.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.

Authors:  William E Klunk; Henry Engler; Agneta Nordberg; Yanming Wang; Gunnar Blomqvist; Daniel P Holt; Mats Bergström; Irina Savitcheva; Guo-feng Huang; Sergio Estrada; Birgitta Ausén; Manik L Debnath; Julien Barletta; Julie C Price; Johan Sandell; Brian J Lopresti; Anders Wall; Pernilla Koivisto; Gunnar Antoni; Chester A Mathis; Bengt Långström
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

Review 10.  Imaging the pathology of Alzheimer's disease: amyloid-imaging with positron emission tomography.

Authors:  William E Klunk; Henry Engler; Agneta Nordberg; Brian J Bacskai; Yanming Wang; Julie C Price; Mats Bergström; Bradley T Hyman; Bengt Långström; Chester A Mathis
Journal:  Neuroimaging Clin N Am       Date:  2003-11       Impact factor: 2.264
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.